ArticleCurrent medicinal chemistry2025

Virtual Screening, Molecular Dynamics Simulation, and Bioactivity Assessment Validate T13074 as a Dual-target EGFR/c-Met Inhibitor.

Dang Fan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.